DNA methylation is an important epigenetic marker information, and obtaining genome-wide methylation level data for all C loci is important for epigenetic spatio-temporal specificity studies. genome-wide DNA methylation sequencing is based on a new generation high-throughput sequencing platform, combined with genome-wide Bisulfite processing and bioinformatics data analysis technology to perform low-cost, high-efficiency and high-accuracy mapping of genome-wide DNA methylation levels.
Many methods take advantage of the high quality and sensitivity of NGS for methylation analysis. Most methods rely on heavy sulfite conversion of DNA to detect unmethylated cytosines. During library preparation, the heavy sulfite converts unmethylated cytosine to uracil. The converted bases are identified as thymine in sequencing (after PCR) and the proportion of methylated cytosines is determined by sequence counting. Heavy sulfite conversion sequencing can be accomplished by targeted methods such as amplicon methylation sequencing (Methyl-seq), or whole genome heavy sulfite sequencing (WGBS). In addition, alternative methods such as TAB-Seq and OxBS also utilize NGS to identify hydroxymethylation (5-hmC) and perform methylation (5-mc) analysis.
CD Genomics is a company that provides professional and comprehensive genome-wide DNA methylation analysis service. We have years of experience to meet your specific project needs in using epigenomics research to add value to your research projects. CD Genomics can provide you with personalized solutions to help you thrive every step of the way around your interest in your workflow. If you would like to know more about this service, please feel free to contact us.
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.